New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics

July 2016

Welcome to the July 2016 issue of PharmSource PERISCOPE

This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.

Enjoy the July issue!

The PharmSource Team


PharmSource Lead Sheet
Summary of Global Clinical Pipeline Activity

Lead Type June 2016 YTD 2016
Early Development 176 650
Late Development 167 667
Biologic 136 558
Small Molecule 341 1423
Parenteral 158 655
Oral 144 560
New Financings 85 483
Total Drug Leads 461 2232
Total Device &
Diagnostic Leads
143 863

*Total leads include acquisitions/alliances, company acquisition/alliances and events.


Pipeline Tip

GenSight Biologics plans to initiate preclinical trials in nonhuman primates with GS030 for retinitis pigmentosa:

  • Therapeutic Area: Ophthalmology
  • Dosage Form: Parenteral, Proprietary device
  • API: Biologic – DNA – Viral vector

Get deeper information about the likely upcoming needs of GenSight, its pipeline, contacts and more in the PharmSource Lead Sheet. If you’re not yet a subscriber, click here to learn more.

Territory Watch: Look Beyond the Usual to Capture New Business

by Katie Ludwick, Marketing Manager

The majority of bio/pharma funding events in the U.S. during 2014 and 2015 occurred outside the high-profile hubs of the San Francisco Bay Area and Boston. However, CROs and CDMOs looking to capture new business will find substantial opportunities in geographically concentrated areas far beyond those more prominent regions.

Business opportunities based on new bio/pharma company financings in geographically compact areas outside the most high-profile venues are truly significant. CROs and CDMOs can strategically focus sales resources in… read on

Times They Are A-Changin’

by Nathaniel Celentano, Business Development Manager

The time of simply answering inbound inquiries or relying on ongoing relationships for new business is once again poised to slow down. Many signs are pointing toward a significant drop in funding, which continues to trend downward, especially from IPOs, leaving attuned vendors to consider more strategic approaches to garnering new business ahead.

When I first started here (2011), the industry was on the tail end of a funding drought due to the historic 2008 recession. This left lots of vendors, especially those with a focus on early stage drug services, fighting for every available project. R&D funding subsequently picked up, and by 2013, capital was flush in the industry, allowing some CMOs and CROs to… read on

Follow the Money to

Medical Device & Diagnostic Opportunities

Spotlight on Mainstay Medical International plc.

Mainstay Medical is a public company based in Ireland that develops innovative therapies for patients with chronic low back pain. They raised $33.9 million in a completion of a secondary public offering.

What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support European commercialization efforts and US clinical trials of its… read on

Follow the Money to

Pharmaceutical Opportunities

Spotlight on Medgenics, Inc.

Medgenics is a U.S. public biopharmaceutical company that develops genomic medicine for the treatment of rare and difficult-to-treat chronic diseases such as anemia, hepatitis and hemophilia. They plan to raise $23 million in a completion of a secondary public offering

What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support product development, research collaborations, intellectual property and patent fees. Likely product development includes… read on

PharmSource Lead Sheet

The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.

Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.

See for yourself how this resource can be a vital tool for building your brand and growing your market share.

To request a test-drive today, contact Nathaniel Celentano at / 1-703-383-4903, ext. 112 (ET USA).